We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

143 hedge funds and large institutions have $556M invested in Albany Molecular Research Inc in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 42 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

493% more call options, than puts

Call options by funds: $1.81M | Put options by funds: $306K

120% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 10

31% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 42

9% more funds holding

Funds holding: 131 → 143 (+12)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

17% less capital invested

Capital invested by funds: $669M → $556M (-$113M)

Holders
143
Holders Change
+12
Holders Change %
+9.16%
% of All Funds
3.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
22
Increased
55
Reduced
42
Closed
10
Calls
$1.81M
Puts
$306K
Net Calls
+$1.51M
Net Calls Change
-$898K

Top Buyers

Rank Fund Capital Flow
1
CCP
Clough Capital Partners
Massachusetts
+$10.2M
2
AAM
AMI Asset Management
California
+$7.73M
3
Morgan Stanley
Morgan Stanley
New York
+$4.83M
4
BFA
BlackRock Fund Advisors
California
+$4.81M
5
ACM
Ashford Capital Management
Delaware
+$3.66M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$32M
2
EAM
EverPoint Asset Management
Connecticut
-$16.2M
3
BM
Bridger Management
New York
-$11.3M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.74M
5
HVC
Healthcare Value Capital
New Jersey
-$3.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$6.39M +$1.33M +65,085 +22%
HA
27
Heartland Advisors
Wisconsin
$4.18M – – –
ACM
28
Ashford Capital Management
Delaware
$3.14M +$3.66M +180,000 New
Natixis Advisors
29
Natixis Advisors
Massachusetts
$3.02M -$36.5K -1,795 -1%
Fisher Asset Management
30
Fisher Asset Management
Washington
$2.98M +$3.48M +170,876 New
SAMC
31
Shinko Asset Management Company
Japan
$2.98M +$3.48M +170,876 New
Principal Financial Group
32
Principal Financial Group
Iowa
$2.95M +$453K +22,271 +15%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$2.83M +$235K +11,546 +8%
Invesco
34
Invesco
Georgia
$2.69M +$1.21M +59,653 +63%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$2.66M +$647K +31,800 +26%
MOACM
36
Mutual of America Capital Management
New York
$2.61M -$1.45M -71,423 -32%
Deutsche Bank
37
Deutsche Bank
Germany
$2.46M +$116K +5,716 +4%
GC
38
Guggenheim Capital
Illinois
$2.42M -$23.6K -1,159 -0.8%
PTC
39
Philadelphia Trust Company
Pennsylvania
$2.41M +$2.76M +135,706 +4,946%
First Trust Advisors
40
First Trust Advisors
Illinois
$2.41M +$2.81M +138,214 New
FSA
41
Franklin Street Advisors
North Carolina
$2.28M -$265K -13,000 -9%
GCP
42
GSA Capital Partners
United Kingdom
$2.25M -$381K -18,700 -13%
Ameriprise
43
Ameriprise
Minnesota
$2.19M +$253K +12,448 +11%
CSC
44
Cove Street Capital
California
$2.09M – – –
Renaissance Technologies
45
Renaissance Technologies
New York
$1.93M +$1.7M +83,557 +306%
AA
46
Ancora Advisors
Ohio
$1.78M -$20.4K -1,000 -1%
BIM
47
BlackRock Investment Management
Delaware
$1.73M +$6.7K +329 +0.3%
EIM
48
Essex Investment Management
Massachusetts
$1.61M +$478K +23,485 +34%
Bessemer Group
49
Bessemer Group
New Jersey
$1.59M – – –
TCIM
50
TIAA CREF Investment Management
New York
$1.47M -$51.6K -2,535 -3%
1
2
3 4 5

AMRI Hedge Fund Activity: Q3 2015 in Review

143 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2015, worth a combined $556M — down 17% from $669M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AMRI positions and 10 closed out — a net gain of 12 holders — while 55 added to existing stakes and 42 trimmed.

The largest buyer was Clough Capital Partners, opening a new position worth an estimated $10.2M. The largest seller was Goldman Sachs, cutting an estimated $32M.

  • 143 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2015, up from 131 in Q2 2015.
  • Funds reported $556M of Albany Molecular Research Inc stock for Q3 2015, down 17% quarter-over-quarter.
  • 22 funds opened new Albany Molecular Research Inc positions in Q3 2015 and 10 closed out, a net change of +12 holders.
  • The largest Albany Molecular Research Inc buyer in Q3 2015 was Clough Capital Partners, an estimated $10.2M added.
  • The largest Albany Molecular Research Inc seller in Q3 2015 was Goldman Sachs, an estimated $32M sold.

Based on aggregated 13F filings for Q3 2015.